New Clinical Trials Available at Texas Retina
At Texas Retina, we remain committed to conducting ongoing research that will advance retinal care. That is why for over 20 years, for physicians have participated in more than 100 national clinical
read more
New Clinical Trials Available at Texas Retina
At Texas Retina Associates, we remain committed to conducting ongoing research that will improve care for our patients, and over the past 20 years, our research program has grown to become one
read more New Clinical Trials Available
At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened
read more
Texas Retina Associates Led the Way at the 2023 VisionWalk to Benefit the Foundation Fighting Blindness
This past Saturday, Texas Retina Associates sponsored and participated in the 2023 Dallas-Fort Worth VisionWalk to benefit the Foundation Fighting Blindness and was recognized as the “Largest Team.” Our “Walk Stars” came
read more
Meet Our Fort Worth Clinical Research Coordinators
Lori Hastings and Tina Bell serve as the clinical research coordinators for our Fort Worth office, managing the enrollment and participation of patients in our clinical trials. These studies explore promising new
read more
Dr. Abbey and Dr. Williams Co-authored Article Published in Ophthalmology on the Influence of Face Mask Use on Endophthalmitis Risk After Eye Injections
Texas Retina Associates’ Ashkan Abbey, MD, and Patrick D. Williams, MD, co-authored a recently published article titled “The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During
read more
Dr. Choi’s Research on Filtering-associated Endophthalmitis in Ophthalmology Retina Journal
Texas Retina Associates’ Rene Y. Choi, MD, PhD, published an article titled “Filtering-Associated Endophthalmitis after Trabeculectomy or Tube-Shunt Implant” in the March 2021 issue of Ophthalmology Retina. The article highlights the results of
read more Dr. Choi’s Research on Utilizing Artificial Intelligence to Aid in the Diagnosis of Plus Disease in Retinopathy of Prematurity Patients Published in Ophthalmology Retina
Texas Retina Associates’ Rene Y. Choi, MD, published an article titled “Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale” in the latest issue of Ophthalmology Retina,
read more Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more